Total Payments
$8,066
2024 Payments
$209.13
Companies
27
Transactions
112
Medicare Patients
3,191
Medicare Billing
$898,260
Payment Breakdown by Category
Food & Beverage$3,714 (46.1%)
Travel$2,351 (29.2%)
Other$2,000 (24.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,714 | 103 | 46.1% |
| Travel and Lodging | $2,351 | 7 | 29.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,000 | 2 | 24.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $4,166 | 25 | $0 (2023) |
| Cyberonics, Inc. | $1,684 | 6 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $461.55 | 11 | $0 (2024) |
| ABBVIE INC. | $241.76 | 4 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $241.59 | 8 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $176.85 | 4 | $0 (2024) |
| Biogen, Inc. | $172.03 | 10 | $0 (2022) |
| UCB, Inc. | $161.23 | 3 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $88.31 | 4 | $0 (2018) |
| Amneal Pharmaceuticals LLC | $80.09 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $209.13 | 10 | Amneal Pharmaceuticals LLC ($80.09) |
| 2023 | $755.75 | 4 | LivaNova USA, Inc. ($709.08) |
| 2022 | $381.54 | 10 | ABBVIE INC. ($225.61) |
| 2021 | $475.41 | 25 | Biogen, Inc. ($76.38) |
| 2020 | $166.54 | 9 | Biogen, Inc. ($74.39) |
| 2019 | $1,467 | 21 | LivaNova USA, Inc. ($1,125) |
| 2018 | $1,612 | 18 | LivaNova USA, Inc. ($1,259) |
| 2017 | $2,998 | 15 | Cyberonics, Inc. ($1,684) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $14.69 | General |
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Central Nervous System | ||||||
| 08/26/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROLOGY | ||||||
| 07/16/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROLOGY | ||||||
| 07/09/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Pain Management | ||||||
| 06/17/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: NEUROLOGY | ||||||
| 04/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: PAIN | ||||||
| 03/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $35.85 | General |
| Category: Neuropsychiatry | ||||||
| 02/12/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROLOGY | ||||||
| 09/15/2023 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | In-kind items and services | $487.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/15/2023 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | In-kind items and services | $221.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/07/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Neuropsychiatry | ||||||
| 05/31/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Neuropsychiatry | ||||||
| 11/29/2022 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $36.65 | General |
| Category: Neurology | ||||||
| 11/03/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $83.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Neuropsychiatry | ||||||
| 08/16/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Neurology | ||||||
| 08/02/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 07/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2022 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Immunology | ||||||
| 05/26/2022 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Neuropsychiatry | ||||||
| 05/24/2022 | Biogen, Inc. | AVONEX (Biological), PLEGRIDY, VUMERITY | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Neurology | ||||||
| 11/19/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 687 | 1,521 | $538,847 | $184,150 |
| 2022 | 9 | 888 | 2,288 | $777,295 | $266,368 |
| 2021 | 8 | 804 | 2,047 | $697,808 | $246,599 |
| 2020 | 6 | 812 | 1,803 | $634,434 | $201,142 |
Total Patients
3,191
Total Services
7,659
Medicare Billing
$898,260
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 209 | 915 | $246,135 | $96,613 | 39.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 240 | 261 | $136,503 | $38,434 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 138 | 234 | $88,452 | $35,233 | 39.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 61 | 61 | $32,757 | $11,327 | 34.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 39 | 50 | $35,000 | $2,544 | 7.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 273 | 1,470 | $395,430 | $135,327 | 34.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 269 | 309 | $161,607 | $53,880 | 33.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 140 | 251 | $94,878 | $38,809 | 40.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 66 | 66 | $35,442 | $12,031 | 33.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 25 | 31 | $15,500 | $8,699 | 56.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 41 | 44 | $26,400 | $8,373 | 31.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 24 | 56 | $14,500 | $5,674 | 39.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 36 | 43 | $30,100 | $2,179 | 7.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 18 | $3,438 | $1,396 | 40.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 254 | 1,308 | $351,852 | $123,363 | 35.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 271 | 305 | $159,515 | $54,315 | 34.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 151 | 289 | $109,242 | $44,532 | 40.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 47 | 47 | $25,239 | $9,234 | 36.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 35 | 37 | $22,200 | $7,211 | 32.5% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 13 | 15 | $7,485 | $4,342 | 58.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 12 | 23 | $6,175 | $2,390 | 38.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 21 | 23 | $16,100 | $1,214 | 7.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 252 | 1,088 | $292,672 | $97,364 | 33.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 273 | 294 | $153,762 | $50,876 | 33.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 164 | 293 | $110,754 | $35,454 | 32.0% |
About Dr. John Karan, M.D
Dr. John Karan, M.D is a Neurology healthcare provider based in Antioch, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720007545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Karan, M.D has received a total of $8,066 in payments from pharmaceutical and medical device companies, with $209.13 received in 2024. These payments were reported across 112 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,714).
As a Medicare-enrolled provider, Karan has provided services to 3,191 Medicare beneficiaries, totaling 7,659 services with total Medicare billing of $898,260. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Antioch, CA
- Active Since 07/19/2006
- Last Updated 12/09/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720007545
Products in Payments
- VNS Therapy (Device) $5,828
- INGREZZA (Drug) $417.60
- NUPLAZID (Drug) $241.59
- UBRELVY (Drug) $208.33
- AJOVY (Drug) $139.36
- Vimpat (Drug) $92.55
- SOLIRIS (Drug) $88.31
- AVONEX (Biological) $85.16
- NURTEC ODT (Drug) $72.21
- Fycompa (Drug) $67.52
- RYTARY (Drug) $65.40
- BRILINTA (Drug) $60.51
- KESIMPTA (Drug) $52.20
- TYSABRI (Biological) $46.99
- Ongentys (Drug) $43.95
- AUBAGIO (Drug) $42.75
- Xadago (Drug) $41.42
- Fintepla (Drug) $36.65
- QULIPTA (Drug) $33.43
- Briviact (Drug) $32.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Antioch
Jessica Weinstein, Md, MD
Neurology — Payments: $6,146
Neurology $6,146
Dr. Robert Cluff, Md, MD
Neurology — Payments: $736.73
Neurology $736.73
Dr. Stacie Daniels, M.d, M.D
Neurology — Payments: $197.46
Neurology $197.46
Dattanand Sudarshana, Md, MD
Neurology — Payments: $193.24
Neurology $193.24
Dr. Santosh Bhaskarabhatla, Md, MD
Neurology — Payments: $118.01
Neurology $118.01